One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-135818
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 23 |
Affiliation: Memorial Sloan Kettering Cancer Center, Washington University in St. Louis, Royal Hobart Hospital, University of California, San Diego, Asan Medical Center, University of Ulsan, Ulsan College, Roche (Canada), Tennessee Oncology, Sarah Cannon, University of Melbourne, St Vincent's Hospital, Royal Adelaide Hospital, Linear Clinical Research, Sir Charles Gairdner Hospital, Hackensack University Medical Center, Jewish General Hospital, City Of Hope National Medical CenterSubcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
